Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Sept 2026 for Thomson Reuters Corporation, €21k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael Bennett Medline: trading record in brief
Michael Bennett Medline has filed trades across 2 companies (mainly through SEDI), most often in Thomson Reuters Corporation and Bank of Nova Scotia, The. Between 5 January 2026 and 15 September 2026, the trades on record add up to 6 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 18 September 2026, reports a share grant of €21k in Thomson Reuters Corporation. Filings reach the SEDI feed a median of 3 days after the trade. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael Bennett Medline
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
325 shares@ CA$105.82Deferred Share UnitsTSXSEDI:4779045
1 shares@ CA$96.98Deferred Share UnitsTSXSEDI:4779041
107 shares@ CA$121.140.0000% mcap13.1% of flowRights Director Deferred Stock Units (DDSU)TSXSEDI:4757139
712 shares@ CA$121.140.0001% mcap86.9% of flowRights Director Deferred Stock Units (DDSU)TSXSEDI:4757136
104 shares@ CA$81.410.0000% mcap100.0% of flowDeferred Share UnitsTSXSEDI:4737178
Deferred Share UnitsTSXSEDI:4737177
6 of 6 declarations
